{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:54:33Z","timestamp":1779904473494,"version":"3.53.1"},"reference-count":76,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>The clonal hematopoiesis of indeterminate potential (CHIP) is a term used to describe individuals who have detectable somatic mutations in genes commonly found in individuals with hematologic cancers but without any apparent evidence of such conditions. The mortality rate in individuals with CHIP is remarkably higher than the influence ascribed to hematologic malignancies, and it is plausible that cardiovascular diseases (CVD) could elucidate the apparent disparity. Studies have shown that the most frequently altered genes in CHIP are associated with the increased incidence of CVDs, type 2 diabetes mellitus (T2DM) and myeloid malignancies, as well as obesity. Additionally, multiple research studies have confirmed that obesity is also independently associated with these conditions, particularly the development and progression of atherosclerotic CVD. Considering the shared pathogenetic mechanisms of obesity and CHIP, our objective in this review was to investigate both preclinical and clinical evidence regarding the correlation between obesity and CHIP and the resulting implications of this interaction on the pathophysiology of CVDs and malignancies. The pro-inflammatory condition induced by obesity and CHIP enhances the probability of developing both diseases and increases the likelihood of developing CVDs, T2DM and malignancies, suggesting that a dangerous vicious loop may exist. However, it is vital to conduct additional research that will suggest targeted treatment options for obese individuals with CHIP in order to reduce harmful effects connected to these conditions.<\/jats:p>","DOI":"10.3390\/life13061365","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T01:28:21Z","timestamp":1686533301000},"page":"1365","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0616-9101","authenticated-orcid":false,"given":"Luka","family":"Komic","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Split-Dalmatia County Health Center, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9696-3359","authenticated-orcid":false,"given":"Marko","family":"Kumric","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia"},{"name":"Laboratory for Cardiometabolic Research, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Urlic","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azer","family":"Rizikalo","sequence":"additional","affiliation":[{"name":"Department of Anatomy, School of Medicine, University of Mostar, 88000 Mostar, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Grahovac","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3536-2713","authenticated-orcid":false,"given":"Jelena","family":"Kelam","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Split-Dalmatia County Health Center, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2148-3227","authenticated-orcid":false,"given":"Marion","family":"Tomicic","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Split-Dalmatia County Health Center, 21000 Split, Croatia"},{"name":"Department of Family Medicine, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7018-4947","authenticated-orcid":false,"given":"Doris","family":"Rusic","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Ticinovic Kurir","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia"},{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-0635","authenticated-orcid":false,"given":"Josko","family":"Bozic","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia"},{"name":"Laboratory for Cardiometabolic Research, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1242\/dev.083147","article-title":"Hematopoiesis","volume":"140","author":"Zon","year":"2013","journal-title":"Development"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13238-019-0633-0","article-title":"New paradigms on hematopoietic stem cell differentiation","volume":"11","author":"Cheng","year":"2020","journal-title":"Protein Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"aan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/287560a0","article-title":"Mutagenic deamination of cytosine residues in DNA","volume":"287","author":"Duncan","year":"1980","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcp.25053","article-title":"Error-Prone Repair of DNA Double-Strand Breaks","volume":"231","author":"Rodgers","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.1074\/jbc.R400006200","article-title":"DNA Replication Fidelity","volume":"279","author":"Kunkel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ng.2271","article-title":"Detectable clonal mosaicism from birth to old age and its relationship to cancer","volume":"44","author":"Laurie","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"ref_9","first-page":"317","article-title":"Clonal Hematopoiesis of Indeterminate Potential","volume":"113","author":"Heuser","year":"2016","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11886-022-01724-2","article-title":"Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk","volume":"24","author":"Haring","year":"2022","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.07.004","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease","volume":"161","author":"Marnell","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2018-01-829937","article-title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","volume":"132","author":"Buscarlet","year":"2018","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.exphem.2022.09.003","article-title":"Role of ASXL1 in hematopoiesis and myeloid diseases","volume":"115","author":"Gao","year":"2022","journal-title":"Exp. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/cas.15294","article-title":"CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression","volume":"113","author":"Liu","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1111\/cas.15094","article-title":"Clonal hematopoiesis and associated diseases: A review of recent findings","volume":"112","author":"Asada","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s43141-021-00205-3","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases\u2014An updated systematic review","volume":"19","author":"Senguttuvan","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2967\/jnumed.107.038661","article-title":"Role of Inflammation in Atherosclerosis","volume":"48","author":"Spagnoli","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_25","unstructured":"(2023, March 19). Obesity and Overweight [Internet]. Who.int. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and Obesity as Determinants of Cardiovascular Risk: The Framingham experience","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.metabol.2018.11.005","article-title":"Obesity and dyslipidemia","volume":"92","author":"Vekic","year":"2019","journal-title":"Metabolism"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.ijo.0802006","article-title":"The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study","volume":"26","author":"Jackson","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/a-1263-0898","article-title":"Metabolic Syndrome Pathophysiology and Predisposing Factors","volume":"42","author":"Bovolini","year":"2021","journal-title":"Int. J. Sports Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.117.029617","article-title":"Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management: Clinical challenges and implications for management","volume":"137","author":"Neeland","year":"2018","journal-title":"Circulation"},{"key":"ref_32","first-page":"e984","article-title":"Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association","volume":"143","author":"Poirier","year":"2021","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/obr.12820","article-title":"Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome","volume":"20","author":"Lim","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2337\/dc10-0744","article-title":"Is Visceral Fat Responsible for the Metabolic Abnormalities Associated With Obesity?: Implications of omentectomy","volume":"33","author":"Klein","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jcmg.2016.10.024","article-title":"Pericardial, But Not Hepatic, Fat by CT Is Associated with CV Outcomes and Structure","volume":"10","author":"Shah","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1210\/jc.2003-030698","article-title":"Echocardiographic Epicardial Adipose Tissue Is Related to Anthropometric and Clinical Parameters of Metabolic Syndrome: A New Indicator of Cardiovascular Risk","volume":"88","author":"Iacobellis","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","first-page":"504","article-title":"Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: A review of the pathophysiology and treatment of obesity","volume":"11","author":"Henning","year":"2021","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCULATIONAHA.107.753483","article-title":"Relation between Body Mass Index, Waist Circumference, and Death after Acute Myocardial Infarction","volume":"118","author":"Zeller","year":"2008","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/CIRCULATIONAHA.106.676379","article-title":"International Day for the Evaluation of Abdominal Obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries: A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries","volume":"116","author":"Balkau","year":"2007","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/eurjpc\/zwac187","article-title":"Obesity and cardiovascular disease: Mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation","volume":"29","author":"Almahmeed","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Perone, F., Pingitore, A., Conte, E., Halasz, G., Ambrosetti, M., Peruzzi, M., and Cavarretta, E. (2023). Obesity and Cardiovascular Risk: Systematic Intervention Is the Key for Prevention. Healthcare, 11.","DOI":"10.3390\/healthcare11060902"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"m3324","DOI":"10.1136\/bmj.m3324","article-title":"Central fatness and risk of all cause mortality: Systematic review and dose-response meta-analysis of 72 prospective cohort studies","volume":"370","author":"Jayedi","year":"2020","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.1999.tb07793.x","article-title":"Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines. Adipocyte-derived Bioactive Substances","volume":"892","author":"Matsuzawa","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose Tissue Dysfunction in Obesity","volume":"117","year":"2009","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.metabol.2013.06.004","article-title":"Adipocytokines in relation to cardiovascular disease","volume":"62","author":"Pauwels","year":"2013","journal-title":"Metabolism"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood-2021-153521","article-title":"Obesity-induced inflammation co-operates with clonal hematopoiesis of indeterminate potential (CHIP) mutants to promote leukemia development and cardiovascular disease","volume":"138","author":"Pasupuleti","year":"2021","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"146S","DOI":"10.1080\/07315724.2002.10719212","article-title":"Regulation of Adiposity and Obesity Risk by Dietary Calcium: Mechanisms and Implications","volume":"21","author":"Zemel","year":"2002","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3389\/fendo.2019.00756","article-title":"The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells","volume":"10","author":"Uzieliene","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.0954-6820.1985.tb08827.x","article-title":"Effect of Nifedipine on Cellular Electrolytes in Fourteen Patients with Untreated Primary Hypertension","volume":"218","author":"Ericsson","year":"2009","journal-title":"Acta Med. Scand."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Guo, D.-Q., Zhang, H., Tan, S.-J., and Gu, Y.-C. (2014). Nifedipine Promotes the Proliferation and Migration of Breast Cancer Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113649"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.atherosclerosis.2021.06.333","article-title":"Clonal hematopoiesis and inflammation in obesity","volume":"331","author":"Tercan","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure through a Mechanism Involving the IL-1\u03b2\/NLRP3 Inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"22596","DOI":"10.1074\/jbc.M112.423145","article-title":"miR-200s Contribute to Interleukin-6 (IL-6)-induced Insulin Resistance in Hepatocytes","volume":"288","author":"Dou","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cbin.10235","article-title":"Concomitant activation of the PI3K\/Akt and ERK1\/2 signalling is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells: Pathways involved in IL-6 secretion in osteocytes","volume":"38","author":"Yin","year":"2013","journal-title":"Cell Biol. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose Tissue, Inflammation, and Cardiovascular Disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"108326","DOI":"10.1016\/j.celrep.2020.108326","article-title":"TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity","volume":"33","author":"Fuster","year":"2020","journal-title":"Cell Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"A66","DOI":"10.1161\/circ.147.suppl_1.66","article-title":"Abstract 66: Clonal Hematopoiesis of Indeterminate Potential and Incident Type 2 Diabetes Risk","volume":"147","author":"Tobias","year":"2023","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e30766","DOI":"10.7554\/eLife.30766","article-title":"Dnmt3a is an epigenetic mediator of adipose insulin resistance","volume":"6","author":"You","year":"2017","journal-title":"eLife"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e72359","DOI":"10.7554\/eLife.72359","article-title":"Constitutive loss of DNMT3A causes morbid obesity through misregulation of adipogenesis","volume":"11","author":"Tovy","year":"2022","journal-title":"eLife"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease","volume":"123","author":"Sano","year":"2018","journal-title":"Circ. Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"van Deuren, R.C., Andersson-Assarsson, J.C., Kristensson, F.M., Steehouwer, M., Sj\u00f6holm, K., Svensson, P.A., Pieterse, M., Gilissen, C., Taube, M., and Jacobson, P. (2021). Expansion of mutation-driven haematopoietic clones is associated with insulin resistance and low HDL-cholesterol in individuals with obesity. bioRxiv.","DOI":"10.1101\/2021.05.12.443095"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e018789","DOI":"10.1161\/JAHA.120.018789","article-title":"Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results from the Women\u2019s Health Initiative","volume":"10","author":"Haring","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","article-title":"Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking","volume":"34","author":"Dawoud","year":"2020","journal-title":"Leukemia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamacardio.2021.1678","article-title":"Association of Diet Quality with Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events","volume":"6","author":"Bhattacharya","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.15585\/mmwr.mm6639e1","article-title":"Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity\u2014United States, 2005\u20132014","volume":"66","author":"Steele","year":"2017","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10555-022-10046-2","article-title":"Obesity: A perfect storm for carcinogenesis","volume":"41","author":"Harris","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/oby.2004.118","article-title":"Resistin, Adiponectin, Ghrelin, Leptin, and Proinflammatory Cytokines: Relationships in Obesity","volume":"12","author":"Vendrell","year":"2004","journal-title":"Obes. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2119\/molmed.2010.00108","article-title":"Adipose and Liver Expression of Interleukin (IL)-1 Family Members in Morbid Obesity and Effects of Weight Loss","volume":"17","author":"Moschen","year":"2011","journal-title":"Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.metabol.2004.07.001","article-title":"Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-\u03b1 and TNF soluble receptors in women with overweight and obesity","volume":"53","author":"Janowska","year":"2004","journal-title":"Metabolism"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaccao.2021.08.011","article-title":"Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Leiva","year":"2021","journal-title":"JACC CardioOncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41591-020-0964-7","article-title":"Myocardial infarction accelerates breast cancer via innate immune reprogramming","volume":"26","author":"Koelwyn","year":"2020","journal-title":"Nat. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2020.04.085","article-title":"De novo malignancy risk in patients undergoing the first percutaneous coronary intervention: A nationwide population-based cohort study","volume":"313","author":"Kwak","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/clpt.2009.312","article-title":"Cancer and Inflammation: Implications for Pharmacology and Therapeutics","volume":"87","author":"Balkwill","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_76","unstructured":"(2023, April 03). Obesity [Internet]. Who.int. Available online: https:\/\/www.who.int\/news-room\/facts-in-pictures\/detail\/6-facts-on-obesity."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/6\/1365\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:52:22Z","timestamp":1760125942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/6\/1365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,10]]},"references-count":76,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["life13061365"],"URL":"https:\/\/doi.org\/10.3390\/life13061365","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,10]]}}}